Two Standards of Care: Understanding the ILADS and IDSA Guidelines

If you've researched Lyme treatment, you've run into a confusing reality: two respected medical organizations offer meaningfully different guidance. Understanding this divide — without being dismissive of either side — helps you make informed decisions and understand why your experience with different doctors can vary so much.

The two guidelines

IDSA (Infectious Diseases Society of America) and ILADS (International Lyme and Associated Diseases Society) both publish Lyme treatment guidelines. They read overlapping evidence and reach different conclusions, especially about persistent symptoms.

The IDSA perspective

• Lyme is generally cured by a defined, relatively short course of antibiotics.
• Ongoing symptoms after treatment are described as "Post-Treatment Lyme Disease Syndrome" (PTLDS) — real, but not, in this view, driven by ongoing infection.
• Extended or repeated antibiotics for persistent symptoms are generally not recommended, citing risks and limited trial evidence.

The ILADS perspective

• Lyme can persist in some patients despite standard treatment.
• Treatment should be individualized, and longer or combination therapy may be appropriate for persistent illness, guided by clinical response.
• Coinfections and the broader systemic picture (see the MSIDS model) must be addressed.
• Decisions should be made through shared, informed decision-making between patient and clinician.

Why reasonable people disagree

The divide comes down to how you weigh:

• The strength and interpretation of clinical trials on retreatment
• Whether persistent symptoms reflect ongoing infection, immune/inflammatory aftermath, or both
• How to balance antibiotic risks against the burden of chronic illness
• How much weight to give patient-reported outcomes

This isn't fringe-versus-mainstream so much as two genuinely different risk-benefit philosophies applied to an area of real scientific uncertainty.

What this means for you as a patient

1. Know which framework your doctor uses. It shapes what they'll offer and how they'll interpret your ongoing symptoms.
2. Informed consent cuts both ways. You deserve to understand the potential benefits and risks of any approach — including long-term antibiotics, which carry real downsides like antibiotic resistance and gut disruption.
3. "Lyme-literate" usually signals an ILADS-aligned approach — one that takes persistent symptoms and coinfections seriously and treats to clinical response.
4. Partnership beats dogma. The best outcomes tend to come from a clinician who explains their reasoning, monitors carefully, and adjusts.

LymeWise presents both perspectives because you deserve the full picture. We are not a substitute for a doctor — our role is to help you ask better questions and find a clinician you trust.

What to do next

• Organize your history with the symptom checker.
• Read how testing fits into diagnosis.
• Find a Lyme-literate certified provider who practices shared decision-making.

This article is educational and does not endorse any specific treatment. All treatment decisions should be made with a qualified clinician who knows your history.